Drugs News and Research

RSS

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).

4 Dec 2017

Computer simulations provide insights into plasmonic nanovesicles for drug delivery

Imagine a microscopic gold pill that could travel to a specific location in your body and deliver a drug just where it is needed. This is the promise of plasmonic nanovesicles.

1 Dec 2017

Laser techniques could help revolutionize understanding of neurodegenerative diseases

Boulder researchers are embarking on a new project to study the progression of neurodegenerative diseases like Alzheimer's by using a new technique to measure neurons firing deep inside animal brains.

1 Dec 2017

Researchers discover ‘brake’ that interferes with HIV's development into infectious agent

Viewed with a microscope, the virus faintly resembles a pineapple--the universal symbol of welcome. But HIV, the virus that causes AIDS, is anything but that. It has claimed the lives of more than 35 million people so far.

1 Dec 2017

Researchers identify vulnerability for glioblastoma subtypes

Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant.

1 Dec 2017

Scientists identifies new genetic changes that increase risk of developing Hodgkin lymphoma

People who inherit genetic changes which alter the function of their immune system are at increased risk of developing Hodgkin lymphoma, a major new study reports.

1 Dec 2017

Desperate for coverage: Are short-term plans better than none at all?

When one of Cindy Holtzman's clients told the Woodstock, Ga., broker he was considering dropping his Affordable Care Act plan because next year's cost approached $23,000 for his family of four, she suggested a new option: a back-to-back set of four, 90-day short-term plans, which would effectively give them a modicum of medical coverage for 2018.

1 Dec 2017

Anti-aging protein could be used as target for rejuvenating cells in the immune system

Anti-aging proteins have long been shown to protect against age-related diseases, such as cancer, neurodegeneration, and cardiovascular disease. A study by researchers at the Gladstone Institutes now reveals that one such protein could also be targeted to rejuvenate cells in the immune system.

1 Dec 2017

New drugs Erenumab and Fremanezumab show promise for migraine

Migraine headaches affect thousands of Americans and millions worldwide. There are several medications that are being prescribed for migraines and for many these do not work well.

30 Nov 2017

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy.

30 Nov 2017

NIH grant supports research on cellular mechanisms governing longevity

The MDI Biological Laboratory has announced that Aric Rogers, Ph.D., has received a grant of $455,000 over two years from the National Institute on Aging, one of the institutes of the National Institutes of Health, for research on the cellular mechanisms governing longevity.

30 Nov 2017

Study shows possibility to have breaks in medication against hormone-sensitive breast cancer

It is possible to have breaks in long-term medication against hormone-sensitive breast cancer - without the effect of the treatment appearing to have been influenced. Women also feel better if they take a three-month break from the hormone treatment each year, according to a medication study reported in The Lancet.

30 Nov 2017

Podcast: ‘What the Health?’ Taxes, Medicare and the year-end mess

Weeks ago, the tax bill under consideration in Congress became a health bill, too. But now it could also trigger major cuts to the Medicare program.

30 Nov 2017

HIV directly impacts the brain in early stages of infection

Stellenbosch University researchers have discovered that the human immunodeficiency virus (HIV) directly impacts the brain in the early stages of the infection.

30 Nov 2017

Review: Program produces positive results for offenders with mental health or addiction issues

A review of a state program launched two years ago to improve recovery and reduce recidivism among felony offenders who have mental health or addiction issues shows the program is producing positive results.

30 Nov 2017

Risk of pneumonic plague epidemic in Madagascar spreading to other nations is limited

Mathematical models have proven the risk of the on-going pneumonic plague epidemic in Madagascar spreading elsewhere in the world is limited, with the estimated number of exported cases staying below 0.1 person in each country between August 1 and October 17.

30 Nov 2017

Understanding molecular mechanisms of signaling pathways to inhibit cancer invasion

The German Research Foundation has approved the renewal application for the Collaborative Research Center 850 "Control of Cell Motility in Morphogenesis, Cancer Invasion, and Metastasis".

30 Nov 2017

Patients with rare diseases and congress square off over orphan drug tax credits

As President Donald Trump talked tax reform on Capitol Hill Tuesday, Arkansas patient advocate Andrea Taylor was also meeting with lawmakers and asking them to save a corporate tax credit for rare disease drug companies.

30 Nov 2017

Researchers discover rare genetic variant that offers protection against Alzheimer's disease

Research published Wednesday in Genome Medicine details a novel and promising approach in the effort to treat Alzheimer's disease.

30 Nov 2017

INRS researchers evaluate how chemotherapy among men affects health of future generations

How do cancer and cancer treatments affect the reproductive function of men? Can this affect the health of their direct descendants and subsequent generations? To get a clear picture, INRS researchers evaluate the current state of knowledge on this public health issue in a review article appearing in the journal Gynécologie Obstétrique & Fertilité.

30 Nov 2017

Drugs News and Research

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

Computer simulations provide insights into plasmonic nanovesicles for drug delivery

Laser techniques could help revolutionize understanding of neurodegenerative diseases

Researchers discover ‘brake’ that interferes with HIV's development into infectious agent

Researchers identify vulnerability for glioblastoma subtypes

Scientists identifies new genetic changes that increase risk of developing Hodgkin lymphoma

Desperate for coverage: Are short-term plans better than none at all?

Anti-aging protein could be used as target for rejuvenating cells in the immune system

New drugs Erenumab and Fremanezumab show promise for migraine

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

NIH grant supports research on cellular mechanisms governing longevity

Study shows possibility to have breaks in medication against hormone-sensitive breast cancer

Podcast: ‘What the Health?’ Taxes, Medicare and the year-end mess

HIV directly impacts the brain in early stages of infection

Review: Program produces positive results for offenders with mental health or addiction issues

Risk of pneumonic plague epidemic in Madagascar spreading to other nations is limited

Understanding molecular mechanisms of signaling pathways to inhibit cancer invasion

Patients with rare diseases and congress square off over orphan drug tax credits

Researchers discover rare genetic variant that offers protection against Alzheimer's disease

INRS researchers evaluate how chemotherapy among men affects health of future generations

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News